News

On 20-21 June, the first Swedish Symposium on Deep Learning will take place in Stockholm. Deep learning is a field of machine learning that builds on complex neural networks – originally used to mimic networks of neurons in the brain. In Vironova’s...

A satisfied and happy Vironova team returned from the BPI trade show in Amsterdam last week. Many visitors came to watch a MiniTEM demo in our beautiful booth and an appreciative and enthusiastic crowd enjoyed the presentation “Automated...

Don’t miss our talk at BPI European Summit: Automated characterization of gene therapy vectors, VLPs and whole viruses. By Josefina Nilsson, head of EM services. April 25, at 15.00 in the vaccine manufacturing stream. A case study how integrity and...

Josefina has extensive experience of characterization of nano-scaled sub-visible particles as a service provider since ten years to the biopharmaceutical industry, from early development to final manufacturing.

Vironova will host a webinar “Automated purity and integrity check of gene therapy vectors” on April 6 at 3 pm CET. (Agenda and registration can be found here.)

A full-day event including live demo of MiniTEM and presentations showing how to go from manual to automated virus particle characterization attracted more than 10 different companies located in Europe. Invited speaker Vesa Turkki, Senior Scientist...

Vironova has established a growing number of global customers in the highly-regulated and quality demanding pharmaceutical industry, who focus on drug/gene delivery and vaccine development. Currently 7 of the 10 largest biopharmaceutical companies...

Vironova has now filed a patent for quantitative analysis of viral vector content using cryoTEM, a method that has already triggered plenty of interest amongst our customers.

Time: 3:00pm London, 10:00am New York

2016 saw Mikael Wik appointed as new CEO and a record sales performance that beat all previous years, with a turnover of 25,9 MSEK. The two founders and previous leaders since 1985 continue to be active in sales and business development.